- Details
- Hielke Martijn de Vries joins Alicia Morgans to discuss immunotherapy with or without radiation therapy for advanced penile cancer patients, the results of the PERICLES study. PERICLES is a phase II trial investigating atezolizumab +/- radiotherapy for advanced squamous cell carcinoma of the penis. Biographies: Hielke Martijn de Vries, Department of Urology, Netherlands Cancer Institute, Amsterdam...
|
- Details
- Charles Ryan is joined by Michael Korn, the Chief Medical Officer of Caris Life Sciences, to discuss the study results assessing the comprehensive genomic profiling of penile squamous cell carcinoma (SCC) and the impact of HPV status on immune-checkpoint inhibition-related biomarkers. Using the Caris Life Sciences dataset, this study aimed to report the landscape of somatic alterations and ICI-rel...
|
- Details
- Alicia Morgans and Giulia Baciarello, discuss the CABA-GCT Study, an academic trial looking at cabazitaxel in patients with refractory germ cell tumors. Biographies: Giulia Baciarello, MD, Medical Oncology 1, Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan, Italy Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at Dana-Farber Ca...
|
- Details
- In a presentation, followed by an educational discussion, from Reza Mehrazin, MD, the topic of management of primary urothelial carcinoma is discussed in depth. Dr. Mehrazin began his presentation with epidemiology and risk factors for this aggressive disease. He discussed the risk factor of advanced age (> 60 years old) along with other less-known risk factors, such as chronic urethral irritation...
|
- Details
- In this conversation with Alicia Morgans, MD, MPH, Siamak (Sia) Daneshmand discusses long-term follow-up of testicular cancer patients, a topic of interest to many navigating testicular cancer survivorship. Dr. Daneshmand provided an oral abstract discussion during the 2021 ASCO annual meeting highlighting two abstracts Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in...
|
- Details
- Silke Gillessen highlights the International Germ Cell Cancer Collaborative Group (IGCCCG) update model for both seminoma and non-seminoma patients highlighting two recently published articles in the Journal of Clinical Oncology, titled "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium" and "Survival and New Prognosticat...
|
- Details
- Darren Feldman, MD, and Charles Ryan, MD, discuss multiple topics in this conversation on testicular germ cell tumors ranging from risk factors, developments in treatment, and the global TIGER study. There is limited data for the association of testis cancer with hereditary cancer genes. In this conversation, Daren Feldman highlights developments in treatment for testicular cancer including the in...
|
- Details
- Scott Petinga, a testicular cancer survivor, patient advocate, and entrepreneur, joins Charles Ryan, MD, to provide an update on his work in the field of testicular cancer advocacy. Scott Petinga shares research advances he is a part of at USC as well as different patient resource avenues like social media groups and online forums for newly diagnosed patients and testicular cancer survivors. Biogr...
|
- Details
- The Testicular Cancer Survivorship Clinic, lead by Adult Nurse Practitioner, Mary Dunn is designed to help patients transition from testicular cancer treatment to testicular cancer survivorship. The Testicular Cancer Survivorship Clinic was established in 2008, at the University of North Carolina. Patients who have completed definitive therapy for testicular cancer are transitioned into the clinic...
|
- Details
- Testicular cancer survivors may experience mental illness as a consequence of their cancer diagnosis and treatment. A recently published article titled, "Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study" focuses on survivorship care plans for testicular cancer patients. In this UroToday Journal Club, Christopher Wallis, MD, Ph.D., an...
|
